Advertisement

Topics

Syntimmune Closes $50M Series B Financing

13:00 EDT 23 Jun 2017 | Drug Discovery Development

Both warm autoimmune hemolytic anemia and pemphigus provide an opportunity to address major unmet medical needs.
Contributed Author: 
Syntimmune
Topics: 

Original Article: Syntimmune Closes $50M Series B Financing

NEXT ARTICLE

More From BioPortfolio on "Syntimmune Closes $50M Series B Financing"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...